ARCHIVES

DCT Board Approves Major Clinical Trials Changes, Regional Groups, New Effort In Surgical Oncology

This article is from The Cancer Letter archive.

Vol. 06 No. 40 | October 10, 1980

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

October 24, 1980

Breast Cancer Plan Issues Its First RFA, Other Initiatives To Be Announced Soon

April 14, 1995

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

NCAB Hears Good News: FY 92 Budget Allows NCI To Increase Levels Of Most Programs

November 29, 1991

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989